126 results
8-K
EX-99.1
EQ
Equillium Inc
9 May 24
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
4:05pm
, and greater employee compensation expenses, which were partially offset by decreases in certain clinical study expenses and greater estimated Australian
S-8
fi7lc2fspzwxg8vv6yaq
25 Mar 24
Registration of securities for employees
4:26pm
S-8
EX-5.1
9obmy3aou
25 Mar 24
Registration of securities for employees
4:26pm
S-8
iit6xeo4o x8e7p
25 Mar 24
Registration of securities for employees
4:26pm
8-K
EX-99.1
nqzp uc0z
25 Mar 24
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
4:05pm
8-K
EX-99.1
7srzu
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.2
rjtso
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
8-K
EX-1.1
v7y4 xm0s234
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
424B5
i7wa18bx5 awm
5 Oct 23
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
8xzqm
9 Aug 23
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
4:06pm